Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Mar;42(3):612-7.
doi: 10.1128/AAC.42.3.612.

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

Affiliations

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

B L Robbins et al. Antimicrob Agents Chemother. 1998 Mar.

Abstract

Bis(isopropyloxymethylcarbonyl) 9-R-(2-phosphonomethoxypropyl)adenine [bis(POC)PMPA] has been identified as a novel prodrug of PMPA. The anti-human immunodeficiency virus activity of bis(POC)PMPA was >100-fold greater than that of PMPA in both an established T-cell line and primary peripheral blood lymphocytes. This improved efficacy was shown to be due to a rapid intracellular uptake of the prodrug resulting in an increased intracellular accumulation of PMPA diphosphate (PMPApp), the pharmacologically active metabolite. PMPApp levels in bis(POC)PMPA-treated cells exceeded by >1,000-fold the levels seen in cells treated with unmodified PMPA in both resting and activated peripheral blood lymphocytes. Significant differences in the intracellular catabolism of PMPA metabolites were noted between the resting and activated lymphocytes. The half-life for the disappearance of PMPApp, derived from either bis(POC)PMPA or PMPA, was 12 to 15 h in the activated lymphocytes and 33 to 50 h in the resting lymphocytes. This long persistence of PMPApp, particularly in resting lymphocytes, may be unique to the nucleoside phosphonate analogs and indicates that effective levels of the active metabolite can be achieved and maintained with relatively infrequent administration of the parent drug.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Structures of PMPA and bis(POC)PMPA.
FIG. 2
FIG. 2
Intracellular metabolism of bis(POC)PMPA in PBMC. R-PBMC (A) and PHA-PBMC (B) were incubated with 1 μM [3H]bis(POC)PMPA. At different intervals, the concentrations of PMPA and its metabolites in cell extracts were analyzed by HPLC as described in Materials and Methods. •, [3H]PMPA; ▪, [3H]PMPAp; ▴, [3H]PMPApp.
FIG. 3
FIG. 3
Catabolism of PMPAp and PMPApp from R-PBMC (A) and PHA-PBMC (B) incubated with 1 μM [3H]bis(POC)PMPA (▾, ▪) or 10 μM [3H]PMPA (▴, •) for 24 h. At different intervals thereafter, cells were analyzed for PMPA metabolites as described in Materials and Methods. The measured t1/2 were calculated from the slopes of the weighted lines generated by linear analysis.

References

    1. Abrahamson K, Erikson B O, Holme E, Jodal U, Lindstedt S, Nordin I. Impaired ketogenesis in carnitine depletion caused by short term administration of pivalic acid prodrug. Biochem Med Metab Biol. 1994;52:18–21. - PubMed
    1. Arimilli M N, Kim C U, Dougherty J, Mulato A, Oliyai R, Shaw J P, Cundy K C, Bischofberger N. Synthesis, in vitro evaluation and oral bioavailability of 9-(2-phosphonomethoxypropyl)adenine prodrugs. Antivir Chem Chemother. 1997;8(6):557–567.
    1. Balzarini J, De Clercq E. Acyclic purine nucleoside phosphonates as retrovirus inhibitors. In: Jeffries D J, De Clercq E, editors. Antiviral chemotherapy. New York, N.Y: John Wiley & Sons; 1995. pp. 41–45.
    1. Balzarini J, Holy A, Jindrich J, Naesens L, Snoeck R, Schols D, De Clercq E. Differential antiherpesvirus and antiretrovirus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob Agents Chemother. 1993;37:332–338. - PMC - PubMed
    1. Balzarini J, Aquaro S, Perno C F, Witvrouw M, Holy A, De Clercq E. Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Biochem Biophys Res Commun. 1996;219:337–341. - PubMed

Publication types

MeSH terms